Ackermann Michael

Track

Insider profile

Performance

Overall performance
3.0
Performance over holding periods
3.0
30 days 90 days 120 days
Average return 2% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
1 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Ackermann Michael's trades of Tarsus Pharmaceuticals, Inc.'s stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2022-05-09 2022-05-05
B Purchase
58,401 -45.9%
422.70
US$4,839,312 		58,401 -45.9% 422.70 US$4,839,312
2021-12-03 2021-12-01
PlS Planned sale
10,510 -20.1%
203.17
US$2,059,244 		10,510 -20.1% 203.17 US$2,059,244
2021-12-03 2021-12-01
PlS Planned sale
37,171 -17.5%
56.91
US$233,070 		37,171 -17.5% 56.91 US$233,070
2021-12-03 2021-12-01
PlS Planned sale
2,054 -0.2%
24.68
US$50,693 		2,054 -0.2% 24.68 US$50,693
2021-12-03 2021-12-01
PlS Planned sale
2,442 -0.2%
23.85
US$58,242 		2,442 -0.2% 23.85 US$58,242
2021-11-03 2021-11-01
PlS Planned sale
869 -0.1%
28.18
US$24,488 		869 -0.1% 28.18 US$24,488
2021-11-03 2021-11-01
PlS Planned sale
4,964 -0.4%
27.76
US$137,801 		4,964 -0.4% 27.76 US$137,801
2021-10-14 2021-10-12
PlS Planned sale
4,517 -0.4%
26.45
US$119,475 		4,517 -0.4% 26.45 US$119,475
2021-10-14 2021-10-12
PlS Planned sale
1,116 -0.1%
25.56
US$28,525 		1,116 -0.1% 25.56 US$28,525
2021-10-12 2021-10-08
PlS Planned sale
200 -0.0%
25.03
US$5,006 		200 -0.0% 25.03 US$5,006